Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187135 · ClinicalTrials.gov registry record · Phase 3
Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration
A Phase 3 study, sponsored by St. Jude Children's Research Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
NCT00187135 is a Phase 3 study that was terminated before completion, run by St. Jude Children's Research Hospital. The registered enrollment target is 168 participants.
The verdict
NCT00187135, a Phase 3 study, was terminated before completion, sponsored by St. Jude Children's Research Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
Study Summary
St. Jude Children's Research Hospital is studying the best ways to prevent pain during and after procedures such as bone marrow aspiration and lumbar puncture with intrathecal (in the spinal fluid) chemotherapy. Researchers will study the effectiveness of combining anesthetics (medicines that help people sleep) and analgesics (medicines that relieve pain). Researchers believe that a combination of fentanyl (analgesic) and propofol (anesthetic), along with applying the skin-numbing-cream EMLA or L.M.X4™ on the area where the procedure is performed, will provide better pain control. Each patient enrolled on this study will have three different anesthetic combinations for three different procedures, in order to determine which combination worked best for each child.
Interventions
- DRUG Propofol
- DRUG Fentanyl
- DRUG EMLA
- DRUG L.M.X4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2002-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187135
The ClinicalTrials.gov registry entry for NCT00187135 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Propofol is the first listed.
NCT00187135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187135 about?
NCT00187135 is a clinical study titled "Study of Fentanyl-Propofol-EMLA of L.M.X4 Technique for Bone Marrow Aspiration". St. Jude Children's Research Hospital is studying the best ways to prevent pain during and after procedures such as bone marrow aspiration and lumbar puncture with intrathecal (in the spinal fluid) chemotherapy. Researchers will study the effectiveness of combining anesthetics (medicines that help p...
What is the current status of trial NCT00187135?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2002-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00187135?
The interventions under investigation include: Propofol (DRUG), Fentanyl (DRUG), EMLA (DRUG), L.M.X4 (DRUG).
Who is sponsoring clinical trial NCT00187135?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.